Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-25

Clinical Trial Update: Hexvix Photodynamic Therapy in Patients With Bladder Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Hexvix photodynamic therapy in patients with intermediate or high-risk bladder cancer has completed, with results reported for this e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hexvix (hexaminolevulinate hydrochloride)

Snippet

Sponsor: Photocure | Conditions: Intermediate or High-risk Bladder Cancer | Phase 1 | Status: COMPLETED